|
CN112094814A
|
|
Method for preparing adenovirus vector vaccine by perfusion culture process
|
|
CN111533792A
|
|
Site-directed mutagenesis carrier protein and application thereof in preparation of vaccine
|
|
CN111217917A
|
|
Novel coronavirus SARS-CoV-2 vaccine and preparation method thereof
|
|
CN110845587A
|
|
Site-directed mutagenesis carrier protein and application thereof in preparation of vaccine
|
|
CN110302375A
|
|
A kind of glycoconjugate and application thereof
|
|
CN109806390A
|
|
A kind of SamRNA vaccine and preparation method thereof
|
|
CN109627320A
|
|
A kind of Brucella antigen Oligosaccharide Protein conjugate, preparation method and its usage
|
|
CN107630004A
|
|
Reduce cell line and construction method and application caused by repeatable adenovirus
|
|
CN107184972A
|
|
A kind of tubercle bacillus OS tb oligosaccharide conjugates and preparation method and application
|
